Calezine 100

देश: न्यूज़ीलैंड

भाषा: अंग्रेज़ी

स्रोत: Ministry for Primary Industries

सक्रिय संघटक:

xylazine

थमां उपलब्ध:

Dechra Veterinary Products NZ Limited

INN (इंटरनेशनल नाम):

xylazine

रचना:

xylazine 100 g/litre

चिकित्सीय क्षेत्र:

Analgesic

प्राधिकरण का दर्जा:

ACVM Registered

प्राधिकरण की तारीख:

2016-09-14

उत्पाद विशेषताएं

Calezine 100
Label Text
October 2018
Page 1 of 4
VIAL
WARNING
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RVM
CALEZINE 100
Xylazine sterile solution 100 mg/mL
Sedative and Analgesic
50 mL net
READ PACKAGE INSERT BEFORE USING THIS PRODUCT
DOSAGE
Horses: 0.5 - 1.1 mg/kg I.V.
1.0 - 2.2 mg/kg I.M.
Deer:
Fallow Deer:
1 - 2 mg/kg I.M.
Red Deer:
0.5 - 1 mg/kg I.M.
Wapiti and Red/Wapiti Cross - 0.5 - 1 mg/kg I.M.
(Generally require high end of Red Deer dose for efficacy)
WITHHOLDING PERIOD
MEAT:
Animals producing meat or offal for human consumption must not be sold
for slaughter either
during treatment or within 3 DAYS of the last treatment.
Store below 25°C. Protect from heat. Do not freeze.
Registered pursuant to the ACVM Act 1997 No. A11354
See www.foodsafety.govt.nz for registration conditions.
Dechra Veterinary Products NZ Ltd
New Zealand
Phone: [phone]
Batch No.
Expiry Date:
Calezine 100
Label Text
October 2018
Page 2 of 4
PACKAGE INSERT
WARNING
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
CALEZINE 100
Xylazine sterile solution 100 mg/mL
Sedative and Analgesic
READ THE ENTIRE LABEL BEFORE USING THIS PRODUCT
PRESENTATION
50 mL multi-dose vial
DESCRIPTION
Calezine 100 is supplied as a sterile solution. Each mL contains
xylazine hydrochloride equivalent to 100 mg of
base activity.
_ _
PHARMACOLOGY
Calezine 100 a non-narcotic compound is an analgesic and sedative as
well as a muscle relaxant. Its analgesic
and sedative activity is related to central nervous system depression.
Its muscle relaxant effect is based on
inhibition of the intraneural transmission of impulses in the central
nervous system. The principal pharmacological
activities develop within 10 to 15 minutes after intramuscular
injection, and within 3 to 5 minutes following
intravenous administration.
A sleeplike state the depth of which is dose dependant is usually
maintained for 1 to 2 hours, while analgesia lasts
from 15 to 30 minutes. The centrally acting muscle-relaxant effect
causes relaxatio